top of page

Disclosure UK 2025: 11th year of industry transparency.

  • Jul 6
  • 1 min read
Today marks the release of the latest Disclosure UK data, highlighting another year of growing transparency across the UK pharmaceutical industry.
Today marks the release of the latest Disclosure UK data, highlighting another year of growing transparency across the UK pharmaceutical industry.


Now in its 11th year, Disclosure UK continues to demonstrate the sector's commitment to openness and accountability, with £929.6 million in total disclosed value reported for 2025 – a 14.3% increase on the previous year. 



Research & Development investment reached £647.3 million, while 99% of non-R&D transfers of value are now published against named individuals or organisations, reflecting continued progress in transparency across the industry. 



At C&C Group, we're proud to support pharmaceutical organisations with specialist solutions that simplify the complex processes behind ABPI Disclosure, helping ensure accurate, compliant and efficient reporting year after year.



As reporting requirements continue to evolve, technology and trusted expertise remain essential in delivering confidence, consistency and compliance.




 
 
 

Comments

bottom of page